James Kennamer, of Raleigh, North Carolina, was selected and recognized as a DASNR 2015 Distinguished Alumni. He graduated from OSU with his bachelor’s degree in 1981 and his Ph.D. in biochemistry in 1986.
After earning his doctorate degree, Kennamer was sought after by some of the world’s most prestigious companies. He has worked his way up the professional chain over is career, holding titles like chemist, research investigator, manager and director.
Along his path, Kennamer’s efforts supported the development of the ACCU-CHEK, a blood glucose test, which is used by diabetics around the world to monitor glucose levels. He also helped develop CoaguCheck, which is utilized to monitor warfarin therapy and reduce the number of life-threatening events and improve the quality of life in patients receiving this therapy.
“We have a lot of challenges facing our healthcare system today and we often look to physicians in hospitals and clinics as the answer to solving all of our problems, and really I think in the long term, we’re going to need to become better stewards of our own health,” said Tom Coon, vice president, dean and director of DASNR. “What that means is that we need not just physicians, nurses and clinicians, but also scientists who can help develop tools and technologies people can use to manage their own health. Dr. Kennamer is a great example of someone who’s done that.”
Since 2007, Kennamer has been the vice president, manufacturing, of Talecris Biotherapeutics/Grifols Therapeutics in Clayton, North Carolina.
Kennamer directs the activities of approximately 800 manufacturing employees engaged in the production, process support and technical transfer of new products into commercial manufacturing. He credits much of his professional success to the educational experience he had at OSU.
“I think we should take great pride in an individual like him who comes from our programs, learned his basic sciences here, developed his expertise as a scientist conducting research here and then has taken that into the private sector and been very successful in the corporate world by developing applications that people can use to manage their own health,” Coon said.
He is a member of the Parenteral Drug Association, the North Carolina Biotechnology Manufacturer’s Forum and serves on the board of the North Carolina State University Biotechnology Training and Education Center Advisory Board.
Also honored as DASNR 2015 Distinguished Alumni were Minnie Lou Bradley and Robert Westerman.
###
Oklahoma State University, in compliance with Title VI and VII of the Civil Rights Act of 1964, Executive Order 11246 as amended, and Title IX of the Education Amendments of 1972 (Higher Education Act), the Americans with Disabilities Act of 1990, and other federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, genetic information, sex, age, sexual orientation, gender identity, religion, disability, or status as a veteran, in any of its policies, practices or procedures. This provision includes, but is not limited to admissions, employment, financial aid, and educational services. The Director of Equal Opportunity, 408 Whitehurst, OSU, Stillwater, OK 74078-1035; phone 405-744-5371; email: [email protected] has been designated to handle inquiries regarding non-discrimination policies: Director of Equal Opportunity. Any person (student, faculty, or staff) who believes that discriminatory practices have been engaged in based on gender may discuss his or her concerns and file informal or formal complaints of possible violations of Title IX with OSU’s Title IX Coordinator 405-744-9154.
REPORTER/MEDIA CONTACT:
Sean Hubbard
Communications Specialist
Agricultural Communications Services
145 Agriculture North
Oklahoma State University
Stillwater, OK 74078
Phone: 405-744-4490
Fax: 405-744-5739
Email: [email protected]
